As part of an ongoing effort to assess the developmental toxicity of selected glycol ethers and their metabolites. Drosophila were exposed throughout development (egg through third instar larva) in culture vials to medium containing equimolar concentrations ( .0013-1.64mM/vial) of triethylene glycol (TEG) and triethylene glycol dimethyl ether (TEGDE). Each vial contained 1 g of powered medium and 5ml of distilled deionized water or a solution of test chemical in water. A mated, untreated, Oregon-R wild-type female was added to each culture vial and allowed to oviposit for 20 hours, then removed. Emerging offspring were collected over 10 days, and examined microscopically (25x) for bent humeral bristles; a morphological defect shown to occur with an increased incidence in flies exposed to developmental toxicants. The incidence of bent bristles was statistically increased (p<0.001) compared to concurrent controls (chi-square) at the two highest TEG concentrations (38/181 at 1.33mM; 29/99 at l.64mM). For TEGDE, the incidence of bent bristles was increased at 0.34mM (10/159; p<0.01) and at 0.66mM (28/171; p<0.001) and 0.99mM (6/25; p<0.001) - no flies emerged at 1.33 and 1.64mM. In contrast to these results, treatment with the documented developmental toxicant 2-methoxyethanol (2ME) resulted in statistically significant increases in bent humeral bristles at concentrations as low as 0.085mM in experiments reported previously using a similar protocol. The results with TEG and TEGDE parallel the developmental toxicity seen in mammals and support further utilization of this Drosophila-based assay as a prescreen for developmental toxicants.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.